Doing More for More: Unintended Consequences of Financial Incentives for Oncology Specialty Care
Brock O’Neil(Vanderbilt University), Matthew J. Resnick(Vanderbilt University Medical Center), David F. Penson(Geriatric Research Education and Clinical Center), Daniel A. Barocas(Vanderbilt University Medical Center), Sam S. Chang(Memorial Sloan Kettering Cancer Center), Amy J. Graves(Vanderbilt University)
Cited by 23
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
Prostate Cancer, Version 1.2016
|Journal of the National Comprehensive Cancer Network|2016|656